A Deep Learning Study on Osteosarcoma Detection from Histological Images

In the U.S, 5-10\% of new pediatric cases of cancer are primary bone tumors. The most common type of primary malignant bone tumor is osteosarcoma. The intention of the present work is to improve the detection and diagnosis of osteosarcoma using computer-aided detection (CAD) and diagnosis (CADx). Such tools as convolutional neural networks (CNNs) can significantly decrease the surgeon's workload and make a better prognosis of patient conditions. CNNs need to be trained on a large amount of data in order to achieve a more trustworthy performance. In this study, transfer learning techniques, pre-trained CNNs, are adapted to a public dataset on osteosarcoma histological images to detect necrotic images from non-necrotic and healthy tissues. First, the dataset was preprocessed, and different classifications are applied. Then, Transfer learning models including VGG19 and Inception V3 are used and trained on Whole Slide Images (WSI) with no patches, to improve the accuracy of the outputs. Finally, the models are applied to different classification problems, including binary and multi-class classifiers. Experimental results show that the accuracy of the VGG19 has the highest, 96\%, performance amongst all binary classes and multiclass classification. Our fine-tuned model demonstrates state-of-the-art performance on detecting malignancy of Osteosarcoma based on histologic images

Artificial intelligence in digital pathology: a diagnostic test accuracy systematic review and meta-analysis

Ensuring diagnostic performance of AI models before clinical use is key to the safe and successful adoption of these technologies. Studies reporting AI applied to digital pathology images for diagnostic purposes have rapidly increased in number in recent years. The aim of this work is to provide an overview of the diagnostic accuracy of AI in digital pathology images from all areas of pathology. This systematic review and meta-analysis included diagnostic accuracy studies using any type of artificial intelligence applied to whole slide images (WSIs) in any disease type. The reference standard was diagnosis through histopathological assessment and / or immunohistochemistry. Searches were conducted in PubMed, EMBASE and CENTRAL in June 2022. We identified 2976 studies, of which 100 were included in the review and 48 in the full meta-analysis. Risk of bias and concerns of applicability were assessed using the QUADAS-2 tool. Data extraction was conducted by two investigators and meta-analysis was performed using a bivariate random effects model. 100 studies were identified for inclusion, equating to over 152,000 whole slide images (WSIs) and representing many disease types. Of these, 48 studies were included in the meta-analysis. These studies reported a mean sensitivity of 96.3% (CI 94.1-97.7) and mean specificity of 93.3% (CI 90.5-95.4) for AI. There was substantial heterogeneity in study design and all 100 studies identified for inclusion had at least one area at high or unclear risk of bias. This review provides a broad overview of AI performance across applications in whole slide imaging. However, there is huge variability in study design and available performance data, with details around the conduct of the study and make up of the datasets frequently missing. Overall, AI offers good accuracy when applied to WSIs but requires more rigorous evaluation of its performance.Comment: 26 pages, 5 figures, 8 tables + Supplementary material

A hybrid ensemble deep learning approach for reliable breast cancer detection

Among the cancer diseases, breast cancer is considered one of the most prevalent threats requiring early detection for a higher recovery rate. Meanwhile, the manual evaluation of malignant tissue regions in histopathology images is a critical and challenging task. Nowadays, deep learning becomes a leading technology for automatic tumor feature extraction and classification as malignant or benign. This paper presents a proposed hybrid deep learning-based approach, for reliable breast cancer detection, in three consecutive stages: 1) fine-tuning the pre-trained Xception-based classification model, 2) merging the extracted features with the predictions of a two-layer stacked LSTM-based regression model, and finally, 3) applying the support vector machine, in the classification phase, to the merged features. For the three stages of the proposed approach, training and testing phases are performed on the BreakHis dataset with nine adopted different augmentation techniques to ensure generalization of the proposed approach. A comprehensive performance evaluation of the proposed approach, with diverse metrics, shows that employing the LSTM-based regression model improves accuracy and precision metrics of the fine-tuned Xception-based model by 10.65% and 11.6%, respectively. Additionally, as a classifier, implementing the support vector machine further boosts the model by 3.43% and 5.22% for both metrics, respectively. Experimental results exploit the efficiency of the proposed approach with outstanding reliability in comparison with the recent state-of-the-art approaches